2020 UAB Cardiovascular Institute Annual Report CVI Annual Report 2019-2020 6

ISCHEMIC HEART DISEASE: INTERVENTIONAL CARDIOLOGY For isolated CABG procedures, *7.66% of participants in the STS that were eligible for the STS Quality Composite rating and received a 3-star with UAB for Harvest #3 2019 (period ended 6/30/19). Participants that receive a 3-star rating have a score significantly higher than the STS mean. This score examines mortality, morbidity (after surgery), and proper medication and IMA usage. Many other institutions are graded using these same four domains that comprise the STS score. Essentially, as the average score of all participants increases, the ability to earn a 3-star rating becomes more difficult. It is important to note that institutions with a 2-star rating also are considered to offer quality care. UAB Interventional Cardiology is an internationally recognized leader in cardiac services, combining compassionate, innovative patient care with the most advanced technology and basic and clinical research. The group attends to patients with a wide range of complex illnesses and disease acuity, ranging from chronic stable ischemic heart disease to cardiogenic shock. *Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database, 2019 Harvest # 3 Report, period ended 6/30/2019 • UAB performs more than 1,000 percutaneous coronary interventions and more than 3,500 cardiac diagnostic studies annually • Regional and state referral center for complex percutaneous coronary interventions, including chronic total occlusion (CTO), which allows many patients to avoid bypass surgery • Intravascular ultrasound (IVUS) and fractionated flow reserve (FFR) technology routinely used to evaluate ischemic lesions • Mechanical circulatory support available for high-risk PCI procedures CABG VOLUMES 2014–2019 ISOLATED CABG: ON-PUMP VS. OFF-PUMP 2014–2019 1000 888 800 650 600 400 631 570 451 427 400 270 334 421 469 59.3% 317 200 0 2014 2015 2016 n TOTAL CABG 2017 HIGHLIGHTS 2018 n ISOLATED CABG 2019 40.7% PCI IN-HOSPITAL RISK-ADJUSTED MORTALITY MEDIAN TIME (MINUTES) TO IMMEDIATE PCI (PATIENTS WITH STEMI) ISCHEMIC HEART DISEASE n OFF-PUMP n ON-PUMP SELECTED PUBLICATION • Vardas PN, Matthews C, Rosati CM, Beckman DJ, Severe Re-Expansion Pulmonary Edema after Conventional Cardiac Surgery: Identification and Management. J Card Surg. 2019 Jun; 34(6):525-527 Source: Cath/PCI NCDR quarter ending Q2 2019 NCDR National Target Goal = 90 Minutes MEDIAN TIME (MINUTES) TO IMMEDIATE PCI (TRANSFER PATIENTS WITH STEMI) NCDR National Target Goal = 120 Minutes SELECTED PUBLICATIONS • Brott BC, Chatterjee A. Drug-Eluting Balloon Therapy for In-Stent Restenosis of Drug-Eluting Stents: Choose and Prepare the Appropriate Lesion. JACC: Cardiovascular Interventions 2018 May 28;11(10):979-80. • Proctor P, Al-Soliman F, Hage FG. Myocardial Perfusion Imaging Prior to Coronary Revascularization: From Risk Stratification to Procedure Guidance. J Nucl Cardiol 2018; doi:10.1007/s12350-018-1221-z. PMID: 29417421 • Doshi R, Patel N. Kaira R, Arora H, Bajaj NS, Arora G, Arora P. Incidence and In-Hospital Outcomes of Single- Vessel Coronary Chronic Total Occlusion Treated with Percutaneous Coronary Intervention. Int J Cardiol. 2018 Oct 15;269:61-66. doi: 10.1016/j.ijcard.2018.07.075. Epub 2018 Jul 19. 6 UAB Cardiovascular Institute Annual Report uabmedicine.org 7

2020 UAB Cardiovascular Institute Annual Report CVI Annual Report 2019-2020 6 | Page 8